{
  "id": 10898901,
  "title": "Gujarat Themis taps private credit to fund JPY21.5bn MicroBiopharm acquisition",
  "url": "https://urgent.news/2026/09/30/gujarat-themis-taps-private-credit-to-fund-jpy21-5bn-microbiopharm",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-30T08:32:32.000Z",
  "source": {
    "name": "Private Equity Wire",
    "slug": "private-equity-wire",
    "url": "https://www.privateequitywire.co.uk/gujarat-themis-taps-private-credit-to-fund-jpy21-5bn-microbiopharm-acquisition/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Indian pharmaceutical company Gujarat Themis Biosyn has secured private credit financing to support its JPY21.5bn ($135m) acquisition of Japanese drugmaker MicroBiopharm Japan, according to a report by Bloomberg.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}